HIV rebound biomarkers give insights into controllers and, unexpectedly, comorbidities July 6, 2021 By Anette Breindl Investigators at the Wistar Institute have identified biomarkers that could discriminate HIV-infected post-treatment controllers, that is, HIV-infected individuals who do not experience viral rebound after analytical treatment interruption.Read More
Vaccinia virus-expressed SARS-CoV-2 spike protein promotes cellular and humoral immunity in mice July 6, 2021
RSS
